These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 7511040)

  • 1. The T classification of clinically localized prostate cancer. An appraisal based on disease outcome after radiation therapy.
    Zagars GK; Geara FB; Pollack A; von Eschenbach AC
    Cancer; 1994 Apr; 73(7):1904-12. PubMed ID: 7511040
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relationship of ultrasound staging and bilateral biopsy positivity to outcome in stage T1c prostate cancer treated with radiotherapy.
    Liebross RH; Pollack A; Lankford SP; von Eschenbach AC; Zagars GK
    Urology; 1998 Oct; 52(4):647-52. PubMed ID: 9763087
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Outcome evaluation of the 1997 American Joint Committee on Cancer staging system for prostate carcinoma treated by radiation therapy.
    Iyer RV; Hanlon AL; Pinover WH; Hanks GE
    Cancer; 1999 Apr; 85(8):1816-21. PubMed ID: 10223577
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prostate cancer and radiation therapy--the message conveyed by serum prostate-specific antigen.
    Zagars GK; Pollack A; von Eschenbach AC
    Int J Radiat Oncol Biol Phys; 1995 Aug; 33(1):23-35. PubMed ID: 7543892
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improved biochemical relapse-free survival with increased external radiation doses in patients with localized prostate cancer: the combined experience of nine institutions in patients treated in 1994 and 1995.
    Kupelian P; Kuban D; Thames H; Levy L; Horwitz E; Martinez A; Michalski J; Pisansky T; Sandler H; Shipley W; Zelefsky M; Zietman A
    Int J Radiat Oncol Biol Phys; 2005 Feb; 61(2):415-9. PubMed ID: 15667961
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prostate carcinoma patients upstaged by imaging and treated with irradiation. An outcome-based analysis.
    Pinover WH; Hanlon A; Lee WR; Kaplan EJ; Hanks GE
    Cancer; 1996 Apr; 77(7):1334-41. PubMed ID: 8608512
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prostate specific antigen as an outcome variable for T1 and T2 prostate cancer treated by radiation therapy.
    Zagars GK
    J Urol; 1994 Nov; 152(5 Pt 2):1786-91. PubMed ID: 7523725
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic factors for clinically localized prostate carcinoma: analysis of 938 patients irradiated in the prostate specific antigen era.
    Zagars GK; Pollack A; von Eschenbach AC
    Cancer; 1997 Apr; 79(7):1370-80. PubMed ID: 9083160
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Do the current subclassifications of stage T3 adenocarcinoma of the prostate have clinical relevance?
    Corn BW; Hanks GE; Lee WR; Schultheiss T
    Urology; 1995 Mar; 45(3):484-9, discussion489-90. PubMed ID: 7533460
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Radiotherapy for localized prostate carcinoma. The correlation of pretreatment prostate specific antigen and nadir prostate specific antigen with outcome as assessed by systematic biopsy and serum prostate specific antigen.
    Crook JM; Bahadur YA; Bociek RG; Perry GA; Robertson SJ; Esche BA
    Cancer; 1997 Jan; 79(2):328-36. PubMed ID: 9010106
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Radiation therapy for T1 and T2 prostate cancer: prostate-specific antigen and disease outcome.
    Zagars GK; Pollack A
    Urology; 1995 Mar; 45(3):476-83. PubMed ID: 7533459
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transrectal ultrasound for staging prostate carcinoma prior to radiation therapy: an evaluation based on disease outcome.
    Liebross RH; Pollack A; Lankford SP; Zagars GK; von Eschenbach AC; Geara FB
    Cancer; 1999 Apr; 85(7):1577-85. PubMed ID: 10193949
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The New American Joint Committee on Cancer and International Union Against Cancer TNM classification of prostate cancer. Clinicopathologic correlations.
    Ohori M; Wheeler TM; Scardino PT
    Cancer; 1994 Jul; 74(1):104-14. PubMed ID: 7516262
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Radical radiation therapy in the management of prostatic adenocarcinoma: the initial prostate specific antigen value as a predictor of treatment outcome.
    Zietman AL; Coen JJ; Shipley WU; Willett CG; Efird JT
    J Urol; 1994 Mar; 151(3):640-5. PubMed ID: 7508522
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prostate-specific antigen and radiation therapy for clinically localized prostate cancer.
    Zagars GK; Pollack A; Kavadi VS; von Eschenbach AC
    Int J Radiat Oncol Biol Phys; 1995 May; 32(2):293-306. PubMed ID: 7538498
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Year of treatment as independent predictor of relapse-free survival in patients with localized prostate cancer treated with definitive radiotherapy in the PSA era.
    Kupelian P; Thames H; Levy L; Horwitz E; Martinez A; Michalski J; Pisansky T; Sandler H; Shipley W; Zelefsky M; Zietman A; Kuban D
    Int J Radiat Oncol Biol Phys; 2005 Nov; 63(3):795-9. PubMed ID: 15925452
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improved clinical staging system combining biopsy laterality and TNM stage for men with T1c and T2 prostate cancer: results from the SEARCH database.
    Freedland SJ; Presti JC; Terris MK; Kane CJ; Aronson WJ; Dorey F; Amling CL;
    J Urol; 2003 Jun; 169(6):2129-35. PubMed ID: 12771734
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Technical and tumor-related factors affecting outcome of definitive irradiation for localized carcinoma of the prostate.
    Perez CA; Lee HK; Georgiou A; Logsdon MD; Lai PP; Lockett MA
    Int J Radiat Oncol Biol Phys; 1993 Jul; 26(4):581-91. PubMed ID: 8330986
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic factors in prostate cancer. Analysis of 874 patients treated with radiation therapy.
    Zagars GK; von Eschenbach AC; Ayala AG
    Cancer; 1993 Sep; 72(5):1709-25. PubMed ID: 7688659
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High dose radiation delivered by intensity modulated conformal radiotherapy improves the outcome of localized prostate cancer.
    Zelefsky MJ; Fuks Z; Hunt M; Lee HJ; Lombardi D; Ling CC; Reuter VE; Venkatraman ES; Leibel SA
    J Urol; 2001 Sep; 166(3):876-81. PubMed ID: 11490237
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.